2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)autosomal erythropoietic protoporphyriaActive, not recruitingPhase 32026-09-09NCT05005975
Immune Response To Intranasal Influenza VaccinationHypertrophy, Infections, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Pharyngeal Diseases, RNA Virus Infections, Stomatognathic Diseases, influenza, otorhinolaryngologic disease, pharyngitis, respiratory system disorder, respiratory tract infectious disorder, tonsillitis, viral infectious diseaseActive, not recruitingNot applicable2023-12-06NCT01866540